← Back to Patent Explorer
US4202323A Expired / Lapsed US ⏱️ 0.0 years remaining

Drug activation by radiation

Assignee: Individual
•
Filing: 1978-04-28
•
Granted: 1980-05-13
•
Expires: 1998-04-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method of selectively causing drug activation within a living body which comprises administering to a living body a polyamino arylmethylnitrile capable of undergoing controlled cleavage to form a polyaminoaryl methyl ion and/or a free cyanide ion, the drug also being soluble in the body serum so that it is capable of passing via oral, intramuscular or intra-peritoneal administration into a body, and then subjecting a localized area of said body to radiation capable of causing cleavage of the cyanide ion from the drug precursor, the resulting ions acting to sensitize the localized area to radiation.

Inventors

  • 👤 Jack Zweig
  • 👤 William McLaughlin
  • 👤 Matthew L. Herz

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 11:41
CPC Classifications
A; A61; A61K; A61K49/00; A61K49/0004; A61K49/0006; A61K31/00; A61K31/275; A61K41/00; A61K41/0042

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 100 words
A method of selectively causing drug activation in a localized area within a living body which comprises administering to said body a substituted aminotriarylacetonitrile capable of undergoing radiation induced cleavage to form a substituted aminotriarylmethyl component and a free cyanide component, said nitrile being soluble in the body serum so that it is capable of passing by the administration thereof to said body, and then subjecting a localized area to radiation capable of causing cleavage of said cyanide species from said nitrile in said localized area, said cyanide ion and/or carbocation acting as a radiation sensitizer in said localized area.
Claim 2
Independent Claim 100 words
A method of selectively causing drug activation in a localized area within a living body which comprises administering to said body a substituted aminotriarylacetonitrile capable of undergoing radiation induced cleavage to form a substituted aminotriarylmethyl component and a free cyanide component, said nitrile being soluble in the body serum so that it is capable of passing by the administration thereof to said body, and then subjecting a localized area to radiation capable of causing cleavage of said cyanide species from said nitrile in said localized area, said cyanide ion and/or carbocation acting as a radiation sensitizer in said localized area.
Claim 3
Dependent Claim 20 words
A method according to claim 1, wherein said aminotriarylacetonitrile is substituted with one or more sulfonic acid or sulfonate groups.
Claim 4
Dependent Claim 15 words
A method according to claim 1, wherein said aminotriarylacetonitrile is the disodium salt of 4-diethylaminophenyl-4',4"-bis-(3-sulfobenzylethylaminophenyl)acetonitrile.
Claim 5
Dependent Claim 12 words
A method according to claim 1, wherein the substituted aminotriarylacetonitrile is hydrophilic.
Claim 6
Dependent Claim 12 words
A method according to claim 1, wherein said radiation is gamma irradiation.
Claim 7
Dependent Claim 12 words
A method according to claim 1, wherein said radiation is x-ray irradiation.
Claim 8
Dependent Claim 12 words
A method according to claim 1, wherein said radiation is ultraviolet irradiation.
Claim 9
Dependent Claim 12 words
A method according to claim 1, wherein said localized area is neoplastic.
Claim 10
Dependent Claim 11 words
A method according to claim 1, wherein said administration is oral.
Claim 11
Dependent Claim 12 words
A method according to claim 1, wherein said administration is by injection.
Claim 12
Dependent Claim 12 words
A method according to claim 10, wherein said injection is given intra-peritoneally.
Claim 13
Dependent Claim 25 words
A method according to claim 3, wherein up to 15 mg/kilo of cyanide was administered to said body in the form of said disodium salt.

References Cited (Backward Citations)

US4106488A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-05-13 1983-11-12 1984-05-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-05-13 1987-11-12 1988-05-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-05-13 1991-11-12 1992-05-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag